
About Adherium
Adherium Limited is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers.
Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place.
Our Vision
To be the leading digital solution for the management of respiratory disease; integrating devices and data to optimise outcomes for patients, healthcare professionals and payers.
Our Values
- Integrity – we are an ethical company that operates with honesty, trust and respect, and conducts our business with the highest of professional standards.
- Innovation – we are passionate about technology and push the boundaries to continually develop and evolve smart solutions that deliver value to physicians and payers and improve patients' lives.
- Accountability - we are a reliable partner and we hold ourselves accountable for our actions and deliver on all our commitments.
- High Performance – we are reliable, collaborative and committed to the highest of standards, keeping quality at the centre of everything we do.
- Customer-Focused – we listen to our customers and continually work to deliver quality products and services, consistently delivering solutions that meet and exceed expectations.
Our People
Meet The Executive Management Team
Adherium has a highly experienced executive team capable of leading the development and execution of our strategic plan.
-
Rick Legleiter
Chief Executive Officer
-
Daniel Kaplon
Chief Financial Officer
-
Geoff Feakes
Chief Technology Officer
-
Francis White
Vice President of Global Business Development
-
Tara Creaven-Capasso
Vice President of Quality, Regulatory and Clinical Affairs
-
Kirsty Rutledge-Malyon
Human Resources Manager
Senior Management
Adherium has a committed, multi-disciplinary management team, focused on achieving our objective of being the international leader in digital solutions for the management of respiratory disease.
Meet The Board of Directors
The Adherium board of directors bring together individuals with multidisciplinary and complementary skill sets which support Adherium’s current and future objectives.
-
Mr Lou Panaccio, BEc, CA, MAICD
Independent Non-Executive Chair
-
Mr Jeremy Curnock Cook, MA
Independent Non-Executive Director
-
Dr William (Bill) Hunter, MD
Independent Non-Executive Director
-
Mr Bruce McHarrie, BCom, FCA, GAICD
Independent Non-Executive Director
-
Mr George Baran, MBA
Non-Executive Director
Our Strategic Partners
Our strategy involves working with leaders in respiratory therapy and technology innovation as we develop next generation technology, and focus commercial efforts in the US.

Planet Innovation
Innovation
Adherium is working with Melbourne-based Planet Innovation to develop software and hardware with physiological data capture that will enable US physicians to be reimbursed for remotely managing their patients via the Hailie® app. This development will further enhance Adherium’s leading device coverage position in both asthma and COPD.
Funding of $5 million for these innovations was secured from the Bioscience Managers Translation Fund 1 in 2020.
The physiological data capture upgrade to Hailie® sensors is expected to be available in 2021.